Previous close | 212.88 |
Open | 212.64 |
Bid | 205.97 x 800 |
Ask | 220.80 x 900 |
Day's range | 211.97 - 217.51 |
52-week range | 132.24 - 237.26 |
Volume | |
Avg. volume | 1,110,142 |
Market cap | 31.855B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 33.41 |
EPS (TTM) | 6.49 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.92 (0.90%) |
Ex-dividend date | 08 May 2024 |
1y target est | 212.34 |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.